Squarepoint Ops LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1642575 NEW YORK, NY

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,833,960

-$759,713 QoQ

Shares Held

410,282

-13.0% QoQ

Ownership

0.143%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $1,094,861,392 across 233 Biotechnology names. TSHA ranks #77 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	426,723	$141,189,839
2	REGN	Regeneron Pharmaceuticals, Inc.	162,814	$125,796,608
3	RPRX	Royalty Pharma plc	1,349,516	$64,736,282
4	IONS	Ionis Pharmaceuticals Inc	695,276	$52,208,274
5	BBIO	BridgeBio Pharma, Inc.	556,324	$41,312,620
6	MDGL	Madrigal Pharmaceuticals, Inc.	52,884	$27,683,187
7	ARQT	Arcutis Biotherapeutics, Inc.	1,103,490	$25,998,224
8	FOLD	AMICUS THERAPEUTICS, INC.	1,705,829	$24,666,287

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,833,960	410,282	-13.0%	Shares	Defined	2026-05-15
2025-12-31	$2,593,673	471,577	+137.7%	Shares	Defined	2026-02-13
2025-09-30	$648,611	198,352	+97.9%	Shares	Defined	2025-11-14
2025-06-30	$231,522	100,226	-52.7%	Shares	Defined	2025-08-27
2024-12-31	$366,486	211,842	+105.4%	Shares	Defined	2025-02-14
2024-09-30	$207,277	103,123	+28.5%	Shares	Defined	2024-11-14
2024-06-30	$179,771	80,255	-62.5%	Shares	Defined	2024-08-14
2024-03-31	$614,025	213,946	+237.0%	Shares	Defined	2024-05-15
2023-12-31	$112,354	63,477	+122.2%	Shares	Defined	2024-02-14
2023-09-30	$90,274	28,568	-64.6%	Shares	Defined	2023-11-14
2023-06-30	$53,299	80,634	+176.0%	Shares	Defined	2023-08-14
2021-12-31	$340,296	29,210	—	Shares	Defined	2022-02-14
No filing history on record for this holder in this stock.